Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patients

Journal of Vascular Surgery

Volumn 36, Issue 2, 2002, Pages 341-345

  Hingorani, Anil ^a   Gramse, Carol ^a   Ascher, Enrico ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL PROTOCOL; FEMALE; HEMATOMA; HUMAN; INTERNATIONAL STANDARD UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE; THROMBOCYTOPENIA; VASCULAR SURGERY;

EID: 0036674089     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.125477     Document Type: Article

References (15)

1. A clinical trial of vena caval filters in the prevention of pulmonary, embolism in patients with proximal deep vein thrombosis
2. A comparison of low-molecular-weight-heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
3. Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously
4. Low molecular weight heparin therapy: Is monitoring needed?
5. Low molecular weight heparins: Practical considerations
6. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low molecular weight heparin
7. The clinical use and laboratory monitoring of low molecular weight heparin, danaparoid, hirudin and related compounds, and argatroban
8. Low-molecular-weight heparin in patients with non-ST-segment elevation acute coronary, syndrome: Role in the emergency department
9. Low molecular weight heparin in acute coronary syndrome: Evidence for superior or equivalent efficacy compared with unfractionated heparin
10. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: A meta-analysis
11. A randomized controlled trial of a low-molecular weight heparin (enoxaparin) to prevent deep vein thrombosis in patients undergoing vascular surgery
12. Low-molecular weight heparin vs. unfractionated heparin in femorodistal reconstructive surgery: A multi-center open randomized study
13. A pilot study on the use of a low-molecular weight heparin (enoxaparin) in arterial reconstructive surgery
14. Low-molecular weight heparin (enoxaparin) versus unfractionated heparin during and after arterial reconstructive surgery: A multi-center randomized study
15. Are low-molecular-weight heparins useful for the prophylaxis and treatment of arterial thrombi?